Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in acute ischaemic stroke: Scientific rationale and available evidence

Acute ischaemic stroke is the result of an abrupt interruption of focal cerebral blood flow. In the majority of cases, this interruption is caused by an acute thromboembolism. Based on clinical experience in the treatment of acute coronary syndromes, platelet glycoprotein (GP) IIb/IIIa receptor anta...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CNS drugs 2004-01, Vol.18 (14), p.981-988
Hauptverfasser:	PANCIOLI, Arthur M, BROTT, Thomas G
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Antianginal agents. Coronary vasodilator agents Biological and medical sciences Brain Ischemia - complications Cardiovascular system Humans Medical sciences Pharmacology. Drug treatments Platelet Aggregation Inhibitors - therapeutic use Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors Randomized Controlled Trials as Topic Secondary Prevention Stroke - drug therapy Stroke - etiology Stroke - prevention & control Thromboembolism - drug therapy Thromboembolism - etiology Thromboembolism - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!